跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
NIOPEG
Authorized
STANDARD
NIOPEG
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4df12766ba5f147f
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
4df12766ba5f147f
Drug Approval Canada Name
NIOPEG
Product Name
NIOPEG
Status
Marketed
Status Date
2025-02-12
Original Market Date
2025-02-12
Din
02546973
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
20:16.00
Atc Original
L03AA13 PEGFILGRASTIM
Atc Name
l 03 aa 13
Aig Number
0149962001
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
PEGFILGRASTIM
6 MG / 0.6 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4df12766ba5f147f
Type
Standard
Back to Health Canada Approvals
NIOPEG - Health Canada Drug Approval Details